ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The investment arms of Pfizer, Eli Lilly & Co., and Johnson & Johnson are among contributors to a $51 million fund raised by Seattle-based Accelerator Corp., which plans to use it to nurture emerging biotech firms in New York City. Accelerator will be based at the Alexandria Center for Life Science, located in the city’s East Side Medical Corridor. Pfizer and Lilly have operations at the Alexandria Center, as does Roche. However, the nascent research hub has been less successful in attracting the smaller firms common in other biotech centers. Accelerator says it has nurtured a dozen early-stage biotech firms in Seattle and seeks to replicate that effort in New York.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter